UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000058326 |
|---|---|
| Receipt number | R000066679 |
| Scientific Title | Research trends on the use of Asenapine for Delirium in Patients with Cancer: A scoping review |
| Date of disclosure of the study information | 2025/06/30 |
| Last modified on | 2025/06/30 22:13:10 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Research trends on the use of Asenapine for Delirium in Patients with Cancer: A scoping review
Acronym
Research trends on the use of Asenapine for Delirium in Patients with Cancer: A scoping review
Scientific Title
Research trends on the use of Asenapine for Delirium in Patients with Cancer: A scoping review
Scientific Title:Acronym
Research trends on the use of Asenapine for Delirium in Patients with Cancer: A scoping review
Region
| Japan |
Condition
Condition
Delirium,Cancer
Classification by specialty
| Hematology and clinical oncology | Psychiatry |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To systematically map existing literature on the use of asenapine for delirium in patients with cancer.
Basic objectives2
Others
Basic objectives -Others
To systematically map existing literature on the use of asenapine for delirium in patients with cancer.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The use of asenapine for patients with cancer and delirium
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Research on the use of asenapine for delirium in cancer patients.
Key exclusion criteria
1.Duplicated publications
2.Conference proceedings
3.Reviews which are not based on systematic review
4.Study protocols
5.Other psychiatric diagnosis (e.g., Schizophrenia, Bipolar disorder)
6.Other neurological diagnosis (e.g., Epilepsy, Parkinson's disease)
7.Articles written in languages other than English or Japanese
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Tetsuro |
| Middle name | |
| Last name | ISHIDA |
Organization
Shiroishi Tomo Mental Clinic
Division name
Department of Psychiatry
Zip code
003-0003
Address
2F Daiichi Kotake Bldg. 1-1-2, Higashi-Sapporo 3-jo 6-chome, Shiroishi-ku, Sapporo, Hokkaido , Japan
TEL
011-598-1439
teturoisida@yahoo.co.jp
Public contact
Name of contact person
| 1st name | Tetsuro |
| Middle name | |
| Last name | ISHIDA |
Organization
Shiroishi Tomo Mental Clinic
Division name
Department of Psychiatry
Zip code
003-0003
Address
2F Daiichi Kotake Bldg. 1-1-2, Higashi-Sapporo 3-jo 6-chome, Shiroishi-ku, Sapporo, Hokkaido , Japan
TEL
011-598-1439
Homepage URL
teturoisida@yahoo.co.jp
Sponsor or person
Institute
Shiroishi Tomo Mental Clinic,Department of Psychiatry,ISHIDA Tetsuro
Institute
Department
Personal name
ISHIDA Tetsuro
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Shiroishi Tomo Mental Clinic
Address
2F Daiichi Kotake Bldg. 1-1-2, Higashi-Sapporo 3-jo 6-chome, Shiroishi-ku, Sapporo, Hokkaido , Japan
Tel
011-598-1439
teturoisida@yahoo.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 06 | Month | 30 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 06 | Month | 30 | Day |
Date of IRB
Anticipated trial start date
| 2025 | Year | 06 | Month | 30 | Day |
Last follow-up date
| 2026 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Data sources and search strategy
The purpose of this study is to comprehensively collect existing literature on the use of asenapine for delirium symptoms in cancer patients and to organize research trends and reported findings. Literature searches will be conducted using PubMed, CINAHL, Cochrane Library, and Medline Web, targeting articles published by June 30, 2025, with the keywords "cancer," "delirium," and "asenapine."
Selection of studies in included studies
Two review authors will independently check to ensure that studies meet the inclusion criteria. Any discrepancies in study selection will be resolved by discussion or discussion with a third author.
Management information
Registered date
| 2025 | Year | 06 | Month | 30 | Day |
Last modified on
| 2025 | Year | 06 | Month | 30 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066679
